|
Human medicines: highlights of 2015
|
22 January 2016 |
|
EMA's medical literature monitoring enters into full operation
|
09 September 2015 |
|
EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
|
21 August 2013 |
|
European Medicines Agency website on suspected side effect reports now in all 23 EU official languages
|
19 June 2012 |
|
European Medicines Agency boosts EU transparency
|
31 May 2012 |
|
European Medicines Agency and United States Food and Drug Administration to share manufacturing site inspections
|
11 December 2011 |
|
European Medicines Agency starts new review of cardiovascular risks of non-selective NSAIDs
|
24 October 2011 |
|
European Medicines Agency reviews further data on narcolepsy and possible association with Pandemrix
|
22 February 2011 |
|
European Medicines Agency completes its review of Avastin used in breast cancer
|
16 December 2010 |
|
European Medicines Agency and ENCePP launch electronic Register of Studies
|
25 November 2010 |
|
European Medicines Agency and U.S. Food and Drug Administration extend confidentiality arrangements
|
20 September 2010 |
|
European Medicines Agency holds international workshop on clinical trials
|
15 September 2010 |
|
European Medicines Agency starts review of Pandemrix
|
31 August 2010 |
|
EMA and US FDA seek potential candidate companies for joint GMP inspection programme
|
12 August 2010 |
|
European Medicines Agency starts review of rosiglitazone-containing medicines
|
15 July 2010 |
|
European Medicines Agency implements internal reorganisation
|
12 October 2009 |
|
The bacterial challenge - time to react
|
18 September 2009 |
|
European Medicines Agency review of pandemic vaccines underway
|
25 July 2009 |
|
European public health agencies evaluate antibiotic resistance of Staphylococcus aureus
|
17 June 2009 |
|
European Medicines Agency recommendations on extension of shelf life for Tamiflu
|
09 May 2009 |